Added to YB: 2026-06-26
Pitch date: 2026-06-24
JSPR [neutral]
Jasper Therapeutics, Inc.
Author Info
Liquidation stocks is focused on liquidation and wind downs of listed stocks. I cover USA, Canada, UK, Europe, Australia, NZL, Japan, Hong Kong and other countries. Sign up for the newsletter.
Company Info
Jasper Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics targeting mast stem cell driven diseases in the United States.
Market Cap
$26.8M
Pitch Price
N/A
Price Target
N/A
Dividend
N/A
EV/EBITDA
-0.20
P/E
-0.39
EV/Sales
N/A
Sector
Biotechnology
Category
special_situation
Liquidations Newsletter - Jasper Therapeutics, Inc.
JSPR (liquidation overview): Mast cell-disease biotech announced strategic review incl. potential wind-up. Going concern warning, burned ~$14M cash last quarter. NAV $0.35 (book value adj for warrant liability).
Read full article (1 min)